Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose simvastatin in multiple myeloma
2005-004933-16Phase 2Completed
- Sponsor
- Department of Haematology
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of simvastatin in multiple myeloma (MM), sponsored by Department of Haematology. Primary endpoint: Treatment response. Started Nov 2005; status: completed.
02
Drugs
simvastatin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2005-004933-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004933-16.